Project Number 3R01AG055422-02S2 Agency/Funding Organization NIA Funding Year 2019 View Full Project Details for Anti-viral Therapy in Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) t. Other Researcher and Organization Principal Investigator DEVANAND, DAVANGERE P Principal Investigator First Name DAVANGERE P Principal Investigator Last Name DEVANAND Awardee Organization COLUMBIA UNIVERSITY Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-591: Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional) FY Overall Cost $200,549 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official RYAN, LAURIE M Related Resources Clinical Trial Anti-viral Therapy in Alzheimer's Disease
